Reviewing the Latest Research on Value-Based Care, Clinical Pathways, and Precision Medicine

ASCO Releases Review of Prominent Commercial Clinical Pathway Vendors

The American Society of Clinical Oncology Task Force assessed 6 national pathway vendors to compare their products against the ASCO Criteria for High-Quality Clinical Pathways.

Read More

 

ICER Report Shows Cost of CAR-T Therapies Align With Clinical Benefit

FDA-approved CAR T-cell therapies may be associated with high costs, but the therapies are priced in alignment with their clinical value.

Read More

 

Real-World Health Care Utilization, Costs of Pulmonary Arterial Hypertension

A recent study evaluated health care utilization and costs of pulmonary arterial hypertension in a real-world setting by comparing periods before and after treatment initiation.

Read More

 

ASCO, NCCN Release Clinical Guidelines for Managing Immunotherapy-Related Toxicities

The American Society of Clinical Oncology and the National Comprehensive Cancer Network have collaborated for the first time to release new clinical guidelines for managing immunotherapy-related toxicities.

Read More

 

Socioeconomic Deprivation, Lower Hospital Treatment Volume Linked With Poor Survival in ALL

Survival outcomes may be worse for patients with ALL living in intermediate and high socioeconomically deprived areas as well as for those treated in hospitals with lower volumes of patients.

Read More

 

Routine Use of Palliative Care Underutilized in Ovarian Cancer

A study found that palliative care for patients with ovarian cancer was often provided later than recommended in national guidelines.

Read More

 

Cost of Chemotherapy Administration Higher in Outpatient Setting Than in Physician Office

Commercial payers are spending almost twice as much on chemotherapy administered in hospital outpatient departments compared with therapy administered in physician offices.

Read More

 

Racial Disparities in Gastric Cancer Preoperative Chemotherapy Use

A National Cancer Database analysis revealed racial and ethnic disparities in patients with gastric cancer in the use of preoperative chemotherapy and in outcomes.

Read More